News
June 2014

Transparency of Clinical Trial Data: Current State of Play

Bio-Science Law Review, Vol 13, Issue 6

By Ian Dodds-Smith Jacqueline Mulryne
Find more content tagged:

People

Ian Dodds-Smith
Ian Dodds-Smith
Partner
London
+44 (0)20 7786 6216
Email
VCard
Jacqueline Mulryne
Jacqueline Mulryne
Partner
London
+44 (0)20 7786 6123
Email
VCard

Related Content

November 23, 2021
Biden Administration Issues Rules Requiring Insurer Transparency on Drug Spending, Rebates and Fees: What Manufacturers Need to Know
Advisory
November 17, 2021
In House Warrior with Daniel Kracov
Podcast
Subscribe
Subscribe Link

Email Disclaimer

Reject Accept